NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

Fortimedix Surgical Announces symphonX Instruments short

Fortimedix Surgical has announced the official U.S. launch of its product line extension with symphonX Instruments short. The new product line offers shorter instruments that broaden surgical applicability of the symphonX Surgical Platform, further increasing the ease of use for surgeons during specific surgical procedures.

symphonX is the world’s lowest profile single-port surgery solution for use in minimally invasive abdominal laparoscopic surgery. The symphonX Instruments portfolio includes various products for grasping, mobilizing, dissecting, retracting, cutting, cauterizing, ligating, and suction/irrigation of tissues and vessels. With this line extension, these different types of instruments are available in a short version. Choosing the appropriate symphonX Instruments for a specific surgical procedure, patient anatomy and/or operative site is at the physician’s discretion.

“This product line extension was developed in response to surgeon feedback,” said David Castiglioni, Vice President Sales of Fortimedix Surgical. “We have used these shorter instruments during cholecystectomy, inguinal hernia repair and several gynecologic procedures including tubal sterilization and ovarian cyst treatment with positive results, confirming the versatility of the platform across surgical specialties. The launch of symphonX Instruments short signifies a substantial milestone as we continue to execute on our strategy to establish broad based market adoption of symphonX and elevate the standard of care in laparoscopy.”

For additional information or product specifications on symphonX instruments short visit www.fortimedixsurgical.com.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X